Suppr超能文献

富血小板血浆在脱发治疗中的应用:临床证据的系统评价与荟萃分析

Platelet-Rich Plasma in the Management of Alopecia: A Systematic Review and Meta-Analysis of Clinical Evidence.

作者信息

Anitua Eduardo, Tierno Roberto, Alkhraisat Mohammad Hamdan

机构信息

BTI Biotechnology Institute, Vitoria, Spain.

University Institute for Regenerative Medicine and Oral Implantology, UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Spain.

出版信息

Dermatol Ther (Heidelb). 2025 Sep 13. doi: 10.1007/s13555-025-01542-8.

Abstract

INTRODUCTION

Alopecia is a common hair loss condition with different treatment modalities. Platelet-rich plasma (PRP), a minimally invasive autologous therapy, has emerged as a topic of interest, but its effectiveness remains debated. The present systematic review and meta-analysis aims to evaluate the safety and efficacy of PRP for alopecia.

METHODS

A comprehensive search of PubMed, EMBASE, and Scopus conducted on 27 May 2025 with monthly updates until July 10 2025 identified 43 randomized controlled trials (1877 participants) assessing PRP in alopecia. Primary outcomes were changes in hair density and thickness. Secondary outcomes included side effects, hair loss, clinical improvement, patient satisfaction, recurrence, and other hair follicle metrics.

RESULTS

Activated PRP was effective in increasing hair density and minimizing recurrence compared with placebo, whereas non-activated PRP was associated with a higher frequency of adverse effects. PRP also improved clinical outcomes and patient satisfaction. Moreover, hair loss decreased with PRP therapy regardless of activation status or control type. However, PRP did not significantly affect hair thickness. However, PRP did not significantly affect hair thickness.

DISCUSSION

These findings support PRP as a relatively safe and effective therapy for alopecia, particularly in increasing hair density and reducing hair loss. Patient satisfaction was generally favorable. The clinical efficacy of PRP was often comparable or superior to conventional treatments. Activation status appears to influence response, highlighting the importance of preparation protocols. However, as a result of heterogeneity in study designs and incomplete reporting of the effect of specific PRP composition-related covariates on treatment efficacy or patient safety outcomes, no significant variation in overall effect modification was attributable to alopecia subtype.

CONCLUSIONS

Moderate evidence highlights that PRP is safe and effective in improving hair density, reducing hair loss, and enhancing clinical outcomes and satisfaction. No significant benefits were demonstrated for hair thickness or other follicle-related parameters as derived from PRP therapy. Further high-quality, standardized trials are needed to confirm these findings and clarify the clinical significance of PRP formulations.

摘要

引言

脱发是一种常见的毛发脱落病症,有不同的治疗方式。富含血小板血浆(PRP),一种微创自体疗法,已成为一个受关注的话题,但其有效性仍存在争议。本系统评价和荟萃分析旨在评估PRP治疗脱发的安全性和有效性。

方法

于2025年5月27日对PubMed、EMBASE和Scopus进行全面检索,并每月更新直至2025年7月10日,共识别出43项评估PRP治疗脱发的随机对照试验(1877名参与者)。主要结局为头发密度和厚度的变化。次要结局包括副作用、脱发、临床改善、患者满意度、复发以及其他毛囊指标。

结果

与安慰剂相比,活化PRP在增加头发密度和减少复发方面有效,而非活化PRP与更高频率的不良反应相关。PRP还改善了临床结局和患者满意度。此外,无论活化状态或对照类型如何,PRP治疗均可减少脱发。然而,PRP对头发厚度没有显著影响。

讨论

这些发现支持PRP作为一种相对安全有效的脱发治疗方法,尤其是在增加头发密度和减少脱发方面。患者满意度总体良好。PRP的临床疗效通常与传统治疗相当或更优。活化状态似乎会影响反应,突出了制备方案的重要性。然而,由于研究设计的异质性以及特定PRP成分相关协变量对治疗效果或患者安全结局影响的报告不完整,脱发亚型对总体效应修饰无显著差异。

结论

中等证据表明,PRP在改善头发密度、减少脱发、提高临床结局和满意度方面是安全有效的。PRP治疗在头发厚度或其他毛囊相关参数方面未显示出显著益处。需要进一步开展高质量、标准化试验来证实这些发现并阐明PRP制剂的临床意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验